Going Beyond SNPs. Polygenic Risk Scoring for a More Personalized Path Forward.
DNA Signature, a next-generation suite of genomic profiles, looks beyond individual variants, combining polygenic risk scoring with clinical interpretation to translate complex genetics into personalized strategies for better health.
Designed as the genetic companion to the Mosaic Diagnostics Organic Acids Test (OAT), DNA Signature – Metabolic Path evaluates foundational genomic variations governing cellular energy production, nutrient utilization, neurotransmitter balance, gut health, methylation/detoxification, and nutrient needs. By assessing interconnected physiological pathways rather than isolated variants, it provides a comprehensive blueprint of baseline biochemistry to help practitioners uncover the underlying drivers of persistent functional imbalances.
Even when standard biomarkers appear within normal reference ranges, subtle genetic variations can significantly alter metabolic throughput. DNA Signature – Metabolic Path bridges this gap, translating complex genetic data into an actionable clinical strategy for targeted nutrient, dietary, lifestyle, and testing protocols.
Designed as the genetic companion to the MosaicDX Organic Acids Test (OAT).
